Considering Rezafungin For Candidemia and Invasive Candidiasis
The antifungal market is limited in terms of development, and when rezafungin (Rezzayo) was FDA approved back in 2023, it became the first new therapy approved to treat candidemia and invasive candidiasis in more than 10 years. Since its approval, additional studies have been done, and rezafungin was shown to be noninferior to caspofungin for […]
Afrigen Biologics Advancing Development of mRNA Vaccine for Rift Valley Fever
Afrigen Biologics, a South African biotechnology company, got $6.2 million in funding from the Coalition for Epidemic Preparedness Innovations (CEPI) to develop the first mRNA-based vaccine for Rift Valley fever (RVF). This funding will advance the vaccine candidate through preclinical development and into Phase I clinical trials, with testing planned in South Africa or another […]
How Immunomics Technology is Leading the Way
Crystal GirodImage Credit: Beckman Coulter Life Sciences The COVID-19 pandemic raised urgent calls from health experts worldwide for governments to form a cohesive strategy to prepare for future pandemics—while also putting measures in place to prevent them. Towards that end, the World Health Organization is leading negotiations for a global pandemic preparedness treaty, and it’s set to […]
FDA Approves Rapid Point-of-Care STI Tests
Cobas liat molecular assays Image credits: Roche diagnostics Roche has received FDA clearance for its cobas liat molecular assays, designed to diagnose sexually transmitted infections (STIs) at the point of care. The tests, which have also been granted a Clinical Laboratory Improvement Amendments (CLIA) waiver, can rapidly detect multiple STIs, including chlamydia, gonorrhea, and Mycoplasma […]
Early Release – Two Human Cases of Fatal Meningoencephalitis Associated with Potosi and Lone Star Virus Infections, United States, 2020–2023 – Volume 31, Number 2—February 2025 – Emerging Infectious Diseases journal
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: Chan–Zuckerberg Biohub, San Francisco, California, USA (C.Y. Chiu); Abbott Pandemic Defense Coalition, Abbott Park, Illinois, USA (C.Y. Chiu, V. Servellita, K. Foresythe); University of California, […]
Early Release – Amebiasis in Mexico, 2014–2023 – Volume 31, Number 2—February 2025 – Emerging Infectious Diseases journal
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: Instituto Politécnico Nacional, Mexico City, Mexico (A. Antonio-Campos); University of Arkansas, Fayetteville, Arkansas, USA (K.J. Farfán-Pira); Benemérita Universidad Autónoma de Puebla, Puebla, Mexico (A.D. Díaz-Fonseca, […]
Early Release – Bayou Hantavirus Cardiopulmonary Syndrome, Louisiana, USA, 2022–2023 – Volume 31, Number 2—February 2025 – Emerging Infectious Diseases journal
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: Louisiana Department of Health, New Orleans, Louisiana, USA (E. Ortega, S. Simonson, T. Sokol); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (E. Shedroff, […]
Early Release – A Pictorial Human Case of “Furious Rabies” – Volume 31, Number 2—February 2025 – Emerging Infectious Diseases journal
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: Azienda Sanitaria Universitaria Giuliano Isontina, “San Giovanni di Dio” Hospital, Gorizia, Italy (A. Perciaccante, M. De Luca); International Society of Iconodiagnosis, Paris, France (A. Perciaccante, […]
Early Release – Cyclospora Genotypic Variations and Associated Epidemiologic Characteristics, United States, 2018–2021 – Volume 31, Number 2—February 2025 – Emerging Infectious Diseases journal
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee, USA (J. Shen); Centers for Disease Control and Prevention, Atlanta, Georgia, USA. (J. Shen, V.A. […]
